The burgeoning application of Large Language Models (LLMs) in Natural Language Processing (NLP) has prompted scrutiny of their domain-specific knowledge processing, especially in the construction industry. Despite high demand, there is a scarcity of ...
With the rapid advancement of Natural Language Processing (NLP) technologies, the application of NLP to enable intelligent syndrome differentiation in Traditional Chinese Medicine (TCM) has become a popular research focus. However, TCM texts contain ...
PURPOSE: Recurrences after curative resection in early-stage and locoregionally advanced non-small cell lung cancer (NSCLC) are common, necessitating a nuanced understanding of associated risk factors. This study aimed to establish a natural language...
Neural networks : the official journal of the International Neural Network Society
Apr 17, 2025
The recent surge in 3D data acquisition has spurred the development of geometric deep learning models for point cloud processing, boosted by the remarkable success of transformers in natural language processing. While point cloud transformers (PTs) h...
BACKGROUND/OBJECTIVES: Reviewing the entire history of imaging exams of a single patient's records is an essential step in clinical practice, but it is time and resource consuming, with potential negative effects on workflow and on the quality of med...
As large language models (LLMs) are increasingly used to address health-related queries, it is crucial that they support their conclusions with credible references. While models can cite sources, the extent to which these support claims remains uncle...
BACKGROUND: Monitoring symptoms of bipolar disorder (BD) is a challenge faced by mental health services. Speech patterns are crucial in assessing the current experiences, emotions, and thought patterns of people with BD. Natural language processing (...
BACKGROUND: Social media is acknowledged by regulatory bodies (eg, the Food and Drug Administration) as an important source of patient experience data to learn about patients' unmet needs, priorities, and preferences. However, current methods rely ei...
BACKGROUND: Remdesivir (RDV) was the first antiviral approved for mild-to-moderate COVID-19 and for those patients at risk for progression to severe disease after clinical trials supported its association with improved outcomes. Real-world evidence (...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.